定量MRI生物标志物可测量肥胖患者靶向脑区的改变
这项前瞻性研究于2019年5月至2022年11月在法国一家大学医院的肥胖照护中心开展,纳入27例肥胖患者和23例年龄性别匹配的正常体重对照,采用定量MRI参数图评估下丘脑和海马。结果显示肥胖患者下丘脑FA更高、QSM更低,海马FA更高、MD更低;影像生物标志物与进食行为或焦虑无相关性。作者认为这些发现与涉及食物摄入的脑区存在神经炎症一致。
要点
- 肥胖患者下丘脑FA高于正常体重对照,QSM低于对照。
- 肥胖患者海马FA高于对照,MD低于对照。
- 影像生物标志物与进食行为或焦虑无相关性。
核心结论
- 研究结果与涉及食物摄入的脑区存在神经炎症一致。
- 定量MRI的活体脑生物标志物似乎可为肥胖患者脑损伤评估提供增量信息。
研究设计与样本
- 前瞻性研究,2019年5月至2022年11月在法国一家大学医院的肥胖照护中心开展。
- 纳入27例肥胖患者和23例年龄及性别匹配的正常体重对照。
- 所有参与者接受脑MRI检查,并评估人体测量学与生物学数据、进食行为、焦虑、抑郁及记忆表现。
- 主要结局指标为脑MRI参数图:定量磁化率图(QSM)、平均扩散率(MD)、各向异性分数(FA)、磁化传递率图及T2弛豫率图。
主要发现
- 下丘脑:肥胖患者FA高于正常体重对照,QSM低于正常体重对照。
- 海马:肥胖患者FA高于正常体重对照,MD低于正常体重对照。
- 影像生物标志物与进食行为或焦虑之间无相关性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Obesity is accompanied by damages to several tissues, including the brain. Pathological data and animal models have demonstrated an increased inflammatory reaction in hypothalamus and hippocampus. OBJECTIVE: We tested whether we could observe such pathological modifications in vivo through quantitative magnetic resonance imaging (MRI) metrics. METHODS: This prospective study was conducted between May 2019 and November 2022. The study was conducted in the Specialized Center for the Care of Obesity in a French University Hospital. Twenty-seven patients with obesity and 23 age and gender-paired normal-weight controls were prospectively recruited. All participants were examined using brain MRI. Anthropometric and biological data, eating behavior, anxiety, depression, and memory performance were assessed in both groups. The main outcome measure was brain MRI with the following parametric maps: quantitative susceptibility mapping (QSM), mean diffusivity (MD), fractional anisotropy (FA), magnetization transfer ratio map, and T2 relaxivity map. RESULTS: In the hypothalamus, patients with obesity had higher FA and lower QSM than normal-weight controls. In the hippocampus, patients with obesity had higher FA and lower MD. There was no correlation between imaging biomarkers and eating behavior or anxiety. CONCLUSION: Our findings are consistent with the presence of neuroinflammation in brain regions involved in food intake. In vivo brain biomarkers from quantitative MRI appear to provide an incremental information for the assessment of brain damages in patients with obesity.
引用
- Baynat L, Yamamoto T, Tourdias T, et al. Quantitative MRI Biomarkers Measure Changes in Targeted Brain Areas in Patients With Obesity. J Clin Endocrinol Metab. 2024. PMID: 38195765. doi:10.1210/clinem/dgae014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。